CP-2569

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCP-2569
Drug Alias NameTNCABL-5583
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalpain 1 inhibitors
TargetsCalpain 1
Therapy Area/IndicationsHypercalcemiaOsteitis DeformansOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesColgate-Palmolive Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypercalcemiaOsteitis DeformansOsteoporosis, Postmenopausal

Other Information

ATC CodeN/A
Related LinksN/A